微创子宫切除术后快速过渡至普遍同日出院的安全性与可行性:一项回顾性前后对比研究
该回顾性前后对比研究在两家高手术量学术及学术附属三级医疗中心开展,比较COVID-19前后两个11个月期间微创子宫切除术后同日出院率。同日出院率从COVID前的1.9%(2/107)升至COVID期间的92%(196/213)(p<.001),30天再入院率与再手术率均为0% vs 0%,无差异。结论认为快速过渡至普遍同日出院安全可行,社区剥夺水平与计划外入院率增加无关。
要点
- 同日出院率从COVID前的1.9%(2/107)升至COVID期间的92%(196/213)(p<.001)。
- 快速实施同日出院后30天再入院率与再手术率均为0% vs 0%,无差异。
- COVID队列中成功同日出院与入院患者在BMI、ASA分级≥2、手术时长、估计出血量、非私人保险、社区剥夺水平、来院时间或距离方面无显著差异。
核心结论
- 为应对COVID-19大流行而快速过渡至普遍同日出院,在良性微创子宫切除术患者中安全可行。
- COVID期间普遍同日出院成功实施,患者再手术率或再入院率未增加。
- 社区剥夺水平与计划外入院率增加无关。
研究设计与样本
- 回顾性前后对比病历审查研究。
- 设置:两家高手术量学术及学术附属三级医疗中心。
- 患者选自两个11个月期间:2018年9月至2019年7月(COVID前)和2020年5月至2021年3月(COVID期间)。
- 干预:腹腔镜或机器人辅助子宫切除术并同日出院。
- 共320例患者符合纳入标准:COVID前107例,COVID期间213例。
主要发现
- 同日出院率从COVID前的1.9%(2/107)升至COVID期间的92%(196/213)(p<.001)。
- 快速实施同日出院后30天再入院率或再手术率无差异(0% vs 0%)。
- COVID-19队列内,成功同日出院与入院患者在体重指数、美国麻醉医师协会分级2级或以上、手术时长、手术完成时间、估计出血量、子宫标本重量、非私人保险、社区剥夺水平、来院时间或距离方面无显著差异。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY OBJECTIVE: The primary objective was to examine the success of rapid implementation of universal same-day discharge (SDD) by examining SDD rates after minimally invasive hysterectomy. The secondary objectives were to explore readmission rates after SDD and the impact of geographic and socio-demographic factors on successful SDD. The relationship between unplanned admission rates and neighborhood-level deprivation, as defined by the Area Deprivation Index, was also examined. DESIGN: Retrospective, before-and-after chart review. SETTING: Two high-volume academic and academic-affiliated tertiary care centers. PATIENTS: Patients were selected from two 11-month periods: September 2018 to July 2019 (pre-COVID) and May 2020 to March 2021 (COVID). INTERVENTIONS: Laparoscopic or robotic assisted hysterectomy with same-day discharge. MEASUREMENTS AND MAIN RESULTS: A total of 320 patients met the inclusion criteria: 107 pre-COVID and 213 COVID. SDD rate increased from 1.9% (2/107) pre-COVID to 92% (196/213) during COVID (p <.001). There was no difference in 30-day readmission rates or re-operation rates after rapid implementation of SDD (0% vs 0%). Within the COVID-19 cohort, there was no significant difference between patients with successful SDD and those admitted with respect to body mass index, American Society of Anesthesiologists class 2 or greater, length of surgery, procedure completion time, estimated blood loss, uterine specimen weight, non-private insurance, neighborhood deprivation level, or time or distance traveled to the hospital. CONCLUSION: Rapid transition to universal SDD in response to the COVID-19 pandemic was safe and feasible in patients undergoing benign minimally invasive hysterectomy. During COVID, universal SDD was implemented successfully in patients without an increase in reoperation or readmission rates. Neighborhood deprivation level is not associated with an increase in unplanned admission rates.
引用
- Cameo T, Requadt E, Okuagu C, et al. Safety and Feasibility of Rapid Transition to Universal Same-Day Discharge After Minimally Invasive Hysterectomy: A Retrospective Before-and-After Study. J Minim Invasive Gynecol. 2025. PMID: 41448361. doi:10.1016/j.jmig.2025.12.025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。